109 related articles for article (PubMed ID: 7692939)
1. Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia.
Lubrano C; Toscano V; Petrangeli E; Spera G; Trotta MC; Rombolà N; Frati L; Di Silverio F; Sciarra F
J Steroid Biochem Mol Biol; 1993 Oct; 46(4):463-8. PubMed ID: 7692939
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasia.
Lubrano C; Petrangeli E; Catizone A; Santonati A; Concolino G; Rombolá N; Frati L; Di Silverio F; Sciarra F
J Steroid Biochem; 1989; 34(1-6):499-504. PubMed ID: 2483222
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptors.
Lubrano C; Sciarra F; Spera G; Petrangeli E; Toscano V; Rombola N; Palleschi F; Palma E; Di Silverio F
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):683-7. PubMed ID: 1373303
[TBL] [Abstract][Full Text] [Related]
4. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
Sciarra F
Ann N Y Acad Sci; 1995 Jun; 761():66-78. PubMed ID: 7542859
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptors in human hyperplastic prostate tissue and their modulation by chronic treatment with a gonadotropin-releasing hormone analog.
Fiorelli G; De Bellis A; Longo A; Natali A; Costantini A; Serio M
J Clin Endocrinol Metab; 1989 Apr; 68(4):740-3. PubMed ID: 2466042
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor is not the major growth-promoting agent in extracts of prostatic tissue.
Story MT; Jacobs SC; Lawson RK
J Urol; 1983 Jul; 130(1):175-9. PubMed ID: 6191046
[TBL] [Abstract][Full Text] [Related]
7. Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate.
Davies P; Eaton CL
Prostate; 1989; 14(2):123-32. PubMed ID: 2469072
[TBL] [Abstract][Full Text] [Related]
8. Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods.
Maddy SQ; Chisholm GD; Hawkins RA; Habib FK
J Endocrinol; 1987 Apr; 113(1):147-53. PubMed ID: 2438365
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.
Myers RB; Kudlow JE; Grizzle WE
Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue.
Glynne-Jones E; Goddard L; Harper ME
Hum Pathol; 1996 Jul; 27(7):688-94. PubMed ID: 8698313
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
12. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines.
Ching KZ; Ramsey E; Pettigrew N; D'Cunha R; Jason M; Dodd JG
Mol Cell Biochem; 1993 Sep; 126(2):151-8. PubMed ID: 7508078
[TBL] [Abstract][Full Text] [Related]
13. Increased soluble EGF after ischemia is accompanied by a decrease in membrane-associated precursors.
Schaudies RP; Johnson JP
Am J Physiol; 1993 Mar; 264(3 Pt 2):F523-31. PubMed ID: 8456964
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor in human breast cancer, endometrial carcinoma and lung cancer. Its relationship to epidermal growth factor receptor, estradiol receptor and tumor TNM.
Bolufer P; Lluch A; Molina R; Alberola V; Vazquez C; Padilla J; Garcia-Conde J; Llopis F; Guillem V
Clin Chim Acta; 1993 Apr; 215(1):51-61. PubMed ID: 8513568
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour.
Maddy SQ; Chisholm GD; Busuttil A; Habib FK
Br J Cancer; 1989 Jul; 60(1):41-4. PubMed ID: 2478180
[TBL] [Abstract][Full Text] [Related]
16. Benign prostatic hyperplasia--video image analysis and its relationship to androgen and epidermal growth factor receptor expression.
Frydenberg M; Foo TM; Jones AS; Grace J; Hensley WJ; Rogers J; Pearson BS; Raghavan D
J Urol; 1991 Sep; 146(3):872-6. PubMed ID: 1714972
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor binding by membranes of human renal cell carcinomas: establishment of an epidermal growth factor receptor assay for clinical use.
Yoshida K; Tosaka A
Int J Urol; 1994 Dec; 1(4):319-23. PubMed ID: 7614394
[TBL] [Abstract][Full Text] [Related]
18. High affinity binding sites for epidermal growth factor (EGF) in renal membranes.
Sack E; Talor Z
Biochem Biophys Res Commun; 1988 Jul; 154(1):312-7. PubMed ID: 3260777
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of transforming growth factor-alpha, epidermal growth factor receptor and c-erbB-2 protein in hyperplastic human prostates.
Giri DK; Pal R; Wadhwa SN; Talwar GP
Carcinogenesis; 1995 Apr; 16(4):729-33. PubMed ID: 7537180
[TBL] [Abstract][Full Text] [Related]
20. Membrane vesicles of A431 cells contain one class of epidermal growth factor binding sites.
Berkers JA; van Bergen en Henegouwen PM; Verkleij AJ; Boonstra J
Biochim Biophys Acta; 1990 May; 1052(3):453-60. PubMed ID: 2354208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
